Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients.
作者信息
Koning Rutger, Bastard Paul, Casanova Jean-Laurent, Brouwer Matthijs C, van de Beek Diederik
机构信息
Department of Neurology, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1100 DD, Amsterdam, The Netherlands.
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, EU, France.
出版信息
Intensive Care Med. 2021 Jun;47(6):704-706. doi: 10.1007/s00134-021-06392-4. Epub 2021 Apr 9.
Abstract
摘要
相似文献
1
Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients.针对I型干扰素的自身抗体与COVID-19患者的多器官衰竭有关。
Intensive Care Med. 2021 Jun;47(6):704-706. doi: 10.1007/s00134-021-06392-4. Epub 2021 Apr 9.
2
Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis.新型冠状病毒肺炎患者体内针对 I 型干扰素的自身抗体：系统评价和荟萃分析。
Int J Infect Dis. 2023 May;130:147-152. doi: 10.1016/j.ijid.2023.03.011. Epub 2023 Mar 11.
3
Interfering with Interferons: A Critical Mechanism for Critical COVID-19 Pneumonia.干扰干扰素：重症 COVID-19 肺炎的关键机制。
Annu Rev Immunol. 2023 Apr 26;41:561-585. doi: 10.1146/annurev-immunol-101921-050835.
4
Type 1 interferons as a potential treatment against COVID-19.1 型干扰素作为一种对抗 COVID-19 的潜在治疗方法。
Antiviral Res. 2020 Jun;178:104791. doi: 10.1016/j.antiviral.2020.104791. Epub 2020 Apr 7.
5
Life-Threatening COVID-19: Defective Interferons Unleash Excessive Inflammation.危及生命的 COVID-19：缺陷型干扰素引发过度炎症。
Med. 2020 Dec 18;1(1):14-20. doi: 10.1016/j.medj.2020.12.001.
6
Immune response in SARS-CoV-2 infection: the role of interferons type I and type III.SARS-CoV-2 感染中的免疫反应：I 型和 III 型干扰素的作用。
Braz J Infect Dis. 2020 Sep-Oct;24(5):428-433. doi: 10.1016/j.bjid.2020.07.011. Epub 2020 Aug 26.
7
Interferon deficiency can lead to severe COVID.干扰素缺乏会导致严重的新冠病毒感染。
Nature. 2020 Nov;587(7834):374-376. doi: 10.1038/d41586-020-03070-1.
8
Auto-antibodies against type I IFNs are associated with severe COVID-19 pneumonia.针对I型干扰素的自身抗体与重症新型冠状病毒肺炎相关。
Signal Transduct Target Ther. 2021 Feb 26;6(1):96. doi: 10.1038/s41392-021-00514-6.
9
Plasmacytoid dendritic cells and type I interferons in flares of systemic lupus erythematosus triggered by COVID-19.新冠病毒引发的系统性红斑狼疮发作中的浆细胞样树突状细胞和I型干扰素
Rheumatol Int. 2021 May;41(5):1019-1020. doi: 10.1007/s00296-021-04825-3. Epub 2021 Mar 5.
10
Autoantibodies to Interferons in Infectious Diseases.自身免疫性干扰素抗体在感染性疾病中的作用。
Viruses. 2023 May 22;15(5):1215. doi: 10.3390/v15051215.
引用本文的文献
1
Distinct circulating autoantibodies are associated with COVID-19 hospitalization and SARS-CoV-2 neutralization activity.不同的循环自身抗体与COVID-19住院治疗及SARS-CoV-2中和活性相关。
Npj Viruses. 2025 Sep 2;3(1):64. doi: 10.1038/s44298-025-00149-2.
2
Toll-like receptor 7 (TLR7)-mediated antiviral response protects mice from lethal SARS-CoV-2 infection.Toll样受体7（TLR7）介导的抗病毒反应可保护小鼠免受致命的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染。
J Virol. 2025 May 20;99(5):e0166824. doi: 10.1128/jvi.01668-24. Epub 2025 Mar 31.
3
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design.I型干扰素自身抗体足迹揭示中和机制并助力抑制性诱饵设计。
J Exp Med. 2025 Jun 2;222(6). doi: 10.1084/jem.20242039. Epub 2025 Mar 20.
4
Autoantibodies in COVID-19: implications for disease severity and clinical outcomes.新冠病毒病中的自身抗体：对疾病严重程度和临床结局的影响
Front Immunol. 2025 Jan 6;15:1509289. doi: 10.3389/fimmu.2024.1509289. eCollection 2024.
5
Similar Kinetics of Pulmonary SARS-CoV-2 Load in Intensive Care Unit Patients with COVID-19 Pneumonia with or Without Autoantibodies Neutralizing Type I Interferons.新冠肺炎合并或不合并中和 I 型干扰素自身抗体的 ICU 患者肺部 SARS-CoV-2 载量的相似动力学。
J Clin Immunol. 2024 Nov 20;45(1):45. doi: 10.1007/s10875-024-01839-x.
6
Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease.患有严重 Powassan、Usutu 或罗斯河病毒病的患者体内的 Auto-Abs 中和 I 型 IFN。
J Exp Med. 2024 Dec 2;221(12). doi: 10.1084/jem.20240942. Epub 2024 Nov 1.
7
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.色素失禁症是导致胸腺发育不良、I 型干扰素自身抗体以及病毒性疾病的原因。
J Exp Med. 2024 Nov 4;221(11). doi: 10.1084/jem.20231152. Epub 2024 Oct 1.
8
A sensitive assay for measuring whole-blood responses to type I IFNs.一种用于测量 I 型干扰素对全血反应的敏感测定法。
Proc Natl Acad Sci U S A. 2024 Oct;121(40):e2402983121. doi: 10.1073/pnas.2402983121. Epub 2024 Sep 23.
9
Human genetic and immunological determinants of SARS-CoV-2 infection and multisystem inflammatory syndrome in children.儿童感染严重急性呼吸综合征冠状病毒2及多系统炎症综合征的人类遗传和免疫决定因素。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae062.
10
Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.在致病性I型干扰素自身抗体触发和终身持续存在之前，就已出现免疫耐受丧失。
J Exp Med. 2024 Sep 2;221(9). doi: 10.1084/jem.20240365. Epub 2024 Jul 17.
Zotero 插件